Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kristine B Patterson

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|June 24, 2009
Maraviroc concentrates in the cervicovaginal fluid and vaginal tissue of HIV-negative womenJulie B Dumond, Kristine B Patterson, Allison L Pecha, et al.
Clinical Pharmacokinetics|October 10, 2012
Pharmacokinetic modelling of efavirenz, atazanavir, lamivudine and tenofovir in the female genital tract of HIV-infected pre-menopausal womenJulie B Dumond, Melanie R Nicol, Racheal N Kendrick, et al.
Science Translational Medicine|December 14, 2011
Penetration of tenofovir and emtricitabine in mucosal tissues: implications for prevention of HIV-1 transmissionKristine B Patterson, Heather A Prince, Eric Kraft, et al.
Antimicrobial Agents and Chemotherapy|July 28, 2006
Dose separation does not overcome the pharmacokinetic interaction between fosamprenavir and lopinavir/ritonavirAmanda H Corbett, Kristine B Patterson, Hsiao-Chuan Tien, et al.
AIDS (London, England)|December 20, 2007
Frequent detection of acute HIV infection in pregnant womenKristine B Patterson, Peter A Leone, Susan A Fiscus, et al.
AIDS (London, England)|August 16, 2013
Differential penetration of raltegravir throughout gastrointestinal tissue: implications for eradication and cureKristine B Patterson, Heather A Prince, Trenton Stevens, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 11, 2012
Protein binding of lopinavir and ritonavir during 4 phases of pregnancy: implications for treatment guidelinesKristine B Patterson, Julie B Dumond, Heather A Prince, et al.
Journal of Clinical Pharmacology|December 18, 2013
Expression of six drug transporters in vaginal, cervical, and colorectal tissues: Implications for drug disposition in HIV preventionMelanie R Nicol, Yuri Fedoriw, Michelle Mathews, et al.
AIDS (London, England)|December 12, 2018
Postpartum HIV care continuum outcomes in the southeastern USAJane S Chen, Brian W Pence, Lisa Rahangdale, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 23, 2012
Single- and multiple-dose pharmacokinetics of darunavir plus ritonavir and etravirine in semen and rectal tissue of HIV-negative menKevin C Brown, Kristine B Patterson, Steven H Jennings, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Journal of Acquired Immune Deficiency Syndromes (1999)|June 24, 2009
Maraviroc concentrates in the cervicovaginal fluid and vaginal tissue of HIV-negative womenJulie B Dumond, Kristine B Patterson, Allison L Pecha, et al.
Clinical Pharmacokinetics|October 10, 2012
Pharmacokinetic modelling of efavirenz, atazanavir, lamivudine and tenofovir in the female genital tract of HIV-infected pre-menopausal womenJulie B Dumond, Melanie R Nicol, Racheal N Kendrick, et al.
Science Translational Medicine|December 14, 2011
Penetration of tenofovir and emtricitabine in mucosal tissues: implications for prevention of HIV-1 transmissionKristine B Patterson, Heather A Prince, Eric Kraft, et al.
Antimicrobial Agents and Chemotherapy|July 28, 2006
Dose separation does not overcome the pharmacokinetic interaction between fosamprenavir and lopinavir/ritonavirAmanda H Corbett, Kristine B Patterson, Hsiao-Chuan Tien, et al.
AIDS (London, England)|December 20, 2007
Frequent detection of acute HIV infection in pregnant womenKristine B Patterson, Peter A Leone, Susan A Fiscus, et al.
AIDS (London, England)|August 16, 2013
Differential penetration of raltegravir throughout gastrointestinal tissue: implications for eradication and cureKristine B Patterson, Heather A Prince, Trenton Stevens, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 11, 2012
Protein binding of lopinavir and ritonavir during 4 phases of pregnancy: implications for treatment guidelinesKristine B Patterson, Julie B Dumond, Heather A Prince, et al.
Journal of Clinical Pharmacology|December 18, 2013
Expression of six drug transporters in vaginal, cervical, and colorectal tissues: Implications for drug disposition in HIV preventionMelanie R Nicol, Yuri Fedoriw, Michelle Mathews, et al.
AIDS (London, England)|December 12, 2018
Postpartum HIV care continuum outcomes in the southeastern USAJane S Chen, Brian W Pence, Lisa Rahangdale, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 23, 2012
Single- and multiple-dose pharmacokinetics of darunavir plus ritonavir and etravirine in semen and rectal tissue of HIV-negative menKevin C Brown, Kristine B Patterson, Steven H Jennings, et al.
Pageof 4